glp-1 news november 2025 today Receptor Agonists and vision risk GLP-1 Pipeline Update: August 2025

Cardiovascular outcomes The EXSCEL trial evaluated the cardiovascular safety of once-weekly exenatide (Bydureon)

In addition to enhancing the bioavailability of drugs, conventional therapies also strive to mitigate systemic toxicity

The FDA permits compounding of medications when commercially available versions are in shortage or when patients require customized formulations

Avoid this by purchasing peptides from a reputable supplier

celimax is 100% made in Korea

The oncedaily Wegovy pill an oral formulation of semaglutide positions the company ahead of its closest rival, Eli Lilly, at a moment when demand for GLP1 therapies is accelerating worldwide